Chromatin Remodeling Agents for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|3|3|192-203

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.3, Iss.3, 2008-09, pp. : 192-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on vascular disrupting agents for cancer therapy

By Korpanty Grzegorz   Brekken Rolf A  

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 403-413

Future Medicine

Access to resources Recommend Favorite

Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 1, 2011-01 ,pp. : 2-19

Bentham Science Publishers

Access to resources Recommend Favorite

Cytosolic and mitochondrial ROS: which one is associated with poor chromatin remodeling?

By Kiani-Esfahani Abbas   Bahrami Solmaz   Tavalaee Marzeyeh   Deemeh Mohammad Reza   Mahjour Amir Ashkan   Nasr-Esfahani Mohammad Hossein  

Systems Biology in Reproductive Medicine, Vol. 59, Iss. 6, 2013-12 ,pp. : 352-359

Informa Healthcare

Access to resources Recommend Favorite

Hydrogen sulfide attenuates cytokine production through the modulation of chromatin remodeling

By          

International Journal of Molecular Medicine, Vol. 35, Iss. 6, 2015-01 ,pp. : 1741-1746

Spandidos Publications

Access to resources Recommend Favorite

Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 4, 2014-10 ,pp. : 449-457

John Wiley & Sons Inc

Access to resources Recommend Favorite